+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Monoclonal Antibody Companies in China

  • PDF Icon

    Report

  • 73 Pages
  • November 2023
  • Region: China
  • AMID Co
  • ID: 3453747

China's demand for Monoclonal Antibody will continue to grow at 12% by 2032

This study focuses on China’s Monoclonal Antibody industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for the consumptions of goods and services. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market.

Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers lack the autonomic intellectual property and financial resources to develop their own brand name products.

This new study analyzes the industry structure, capacities and output. Major producers' production locations, market shares and profiles are presented. The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and the in-house databases.

Table of Contents

I. INTRODUCTION
  • Report Scope and Methodology
  • Executive Summary
III. MONOCLONAL ANTIBODY INDUSTRY ASSESSMENTS
  • Monoclonal Antibody Industry Structure
  • Market Size
  • Market Growth Drivers
  • Monoclonal Antibody Sales Volume
  • Major Producer Facility Locations and Sales Volume
  • Market Share of Key Producers
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development
VII. MONOCLONAL ANTIBODY PRODUCER DIRECTORY
  • Profiles of Monoclonal Antibody Producers
LIST OF TABLES
I. INTRODUCTION
  • Economic Outlook Summary
III. MONOCLONAL ANTIBODY INDUSTRY ASSESSMENTS
  • Monoclonal Antibody Sales Volume by Drugs Classification
  • Monoclonal Antibody Sales Volume
  • Major Producer Facility Location
  • Major Monoclonal Antibody Producer Sales Volume
  • Market Share of Key Producers
  • Major Foreign Investment in China
LIST OF CHARTS
I. INTRODUCTION
  • Monoclonal Antibody Sales Volume
III. MONOCLONAL ANTIBODY INDUSTRY ASSESSMENTS
  • Monoclonal Antibody Sales Volume by Drugs Classification
  • Monoclonal Antibody Sales Volume
  • Monoclonal Antibody Production

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Shanghai Roche Pharmacy Co., Ltd.
  • Wuhan Institute of Biological Products(WIBP)